Odd Helge Gilja
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Odd Helge Gilja has a total of 265 co-authors. Here are the top co-authors by number of shared publications:
Trygve Hausken
Section for Gastroenterology, Department of Clinical Medicine, University of Bergen, 5021 Bergen, Norway ; National Centre for Ultrasound in Gastroenterology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway
17 shared publications- Trygve Hausken
Department of Clinical Medicine, University of Bergen, 5021 Bergen, Norway
12 shared publications Svein Ødegaard
9 shared publications- Spiros Kotopoulis
National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Jonas Lies vei 83, 5021, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Jonas Lies vei 91 B, 5021, Bergen, Norway
8 shared publications - Hans Gregersen
California Medical Innovations Institute San Diego California USA
7 shared publications - Magdy El-Salhy
Department of Clinical Medicine, University of Bergen, Bergen, Norway
7 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (17) , 2816
Comparison of Ultrasound and Scintigraphy in Gastric Emptying: A Comprehensive Review
Gastric emptying is the process by which gastric contents are transferred from the stomach to the small intestine for further digestion and nutrient absorption. It is the result of multiple gastrointestinal mechanisms and is essential for understanding the kinetics of digestion in humans. Delayed gastric emptying is clinically relevant as it is commonly observed in conditions such as gastroparesis and functional dyspepsia. A wide range of diagnostic modalities are available to assess gastric emptying, including scintigraphy, ultrasonography, magnetic resonance imaging, gastric aspiration, and stable isotope breath tests. Scintigraphy is widely regarded as the ‘gold standard’ technique, as it enables a direct quantitative assessment of gastric emptying following ingestion of a radiolabeled meal(s). Scintigraphy is non-invasive, reproducible, widely available, and well tolerated; however, it lacks standardized protocols, is time-consuming, costly, and necessitates exposure to ionizing radiation. Although the radiation dose is low, cumulative exposure remains a concern, particularly in pediatric and pregnant populations. In contrast, ultrasonography is safe, non-invasive, portable, inexpensive, and free from radiation exposure. Nevertheless, the application of ultrasound is limited by operator dependency and the need for technical expertise, and image quality may be affected by factors such as obesity and intraluminal gas. Furthermore, there is substantial methodological variability across studies, and its use in assessing gastric emptying of semisolid and solid meals is less well established. 3D ultrasonography, in particular, shows promise as a safe, non-invasive method for assessing gastric emptying. Further studies are required to promote the consistent application of established scintigraphic gastric emptying protocols across centers and to validate 3D ultrasound, particularly with solid meals, to potentially enhance its role as an alternative to scintigraphy. This article represents a comprehensive review based on a structured literature search with the primary aim of comparing ultrasonographic and scintigraphic measurements of gastric emptying, including the advantages and disadvantages of both methods.
- 1 September 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (17) , 2816
Open AccessComparison of Ultrasound and Scintigraphy in Gastric Emptying: A Comprehensive Review
Gastric emptying is the process by which gastric contents are transferred from the stomach to the small intestine for further digestion and nutrient absorption. It is the result of multiple gastrointestinal mechanisms and is essential for understanding the kinetics of digestion in humans. Delayed gastric emptying is clinically relevant as it is commonly observed in conditions such as gastroparesis and functional dyspepsia. A wide range of diagnostic modalities are available to assess gastric emptying, including scintigraphy, ultrasonography, magnetic resonance imaging, gastric aspiration, and stable isotope breath tests. Scintigraphy is widely regarded as the ‘gold standard’ technique, as it enables a direct quantitative assessment of gastric emptying following ingestion of a radiolabeled meal(s). Scintigraphy is non-invasive, reproducible, widely available, and well tolerated; however, it lacks standardized protocols, is time-consuming, costly, and necessitates exposure to ionizing radiation. Although the radiation dose is low, cumulative exposure remains a concern, particularly in pediatric and pregnant populations. In contrast, ultrasonography is safe, non-invasive, portable, inexpensive, and free from radiation exposure. Nevertheless, the application of ultrasound is limited by operator dependency and the need for technical expertise, and image quality may be affected by factors such as obesity and intraluminal gas. Furthermore, there is substantial methodological variability across studies, and its use in assessing gastric emptying of semisolid and solid meals is less well established. 3D ultrasonography, in particular, shows promise as a safe, non-invasive method for assessing gastric emptying. Further studies are required to promote the consistent application of established scintigraphic gastric emptying protocols across centers and to validate 3D ultrasound, particularly with solid meals, to potentially enhance its role as an alternative to scintigraphy. This article represents a comprehensive review based on a structured literature search with the primary aim of comparing ultrasonographic and scintigraphic measurements of gastric emptying, including the advantages and disadvantages of both methods.
- Open Access
- 30 July 2026
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 32 (3) , 449-463
Possible Mechanisms Underlying the Effects of Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome
Magdy El-Salhy, Tora Skarvatun, Dag Arne Lihaug Hoff, Johan Lunding, Elisabeth Kjelsvik Steinsvik, Odd Helge Gilja, and Jan Gunnar Hatlebakk. J Neurogastroenterol Motil 2026;32:449-63. https://doi.org/10.5056/jnm26028
- 30 July 2026
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 32 (3) , 449-463
Open AccessPossible Mechanisms Underlying the Effects of Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome
Magdy El-Salhy, Tora Skarvatun, Dag Arne Lihaug Hoff, Johan Lunding, Elisabeth Kjelsvik Steinsvik, Odd Helge Gilja, and Jan Gunnar Hatlebakk. J Neurogastroenterol Motil 2026;32:449-63. https://doi.org/10.5056/jnm26028
- Open Access
- 17 November 2025
- Published by Medical Communications Sp. z.o.o. in Journal of Ultrasonography
- Vol. 25 (103) , 31
Comparison of two- and three-dimensional ultrasound for volume estimation of the meal-stimulated gallbladder
Aim: To compare two- and three-dimensional (2D and 3D) ultrasound of the gallbladder in an adult cohort. Material and methods: In this observational, cross-sectional study, gallbladder volumes were measured using 2D and 3D ultrasound. Examinations were performed in the fasting state and at predefined time intervals after ingestion of a standardized nutritional drink. At each time point, measurements were performed twice using 2D and twice using 3D ultrasound. Volumes were calculated using the ellipsoid method for 2D ultrasound. For 3D, manual tracing was performed. Results: Sixty-two subjects were included, yielding 2,328 volume measurements. The mean age was 69 years (SD 6.6) and the median BMI was 24.3 kg/m2 (IQR 22.9–28.6). The mean difference between 2D measurements was significantly larger than the difference between 3D measurements (3.3 cm3 vs. 1.9 cm3, p <0.001). The intraclass correlation coefficient (ICC) between two sequential 2D measurements was 0.94 (p <0.001, 95% CI 0.94–0.95), and between two sequential 3D measurements 0.96 (p <0.001, 95% CI 0.96–0.97). The ICC between 2D and 3D measurements was 0.85 (95% CI 0.74–0.91, p <0.001). Conclusions: Our findings indicate that 3D ultrasound exhibits lower intra-observer variation when determining gallbladder volumes compared to 2D ultrasound. The discrepancy between the two methods increases with gallbladder volume.
- 17 November 2025
- Published by Medical Communications Sp. z.o.o. in Journal of Ultrasonography
- Vol. 25 (103) , 31
Open AccessComparison of two- and three-dimensional ultrasound for volume estimation of the meal-stimulated gallbladder
Aim: To compare two- and three-dimensional (2D and 3D) ultrasound of the gallbladder in an adult cohort. Material and methods: In this observational, cross-sectional study, gallbladder volumes were measured using 2D and 3D ultrasound. Examinations were performed in the fasting state and at predefined time intervals after ingestion of a standardized nutritional drink. At each time point, measurements were performed twice using 2D and twice using 3D ultrasound. Volumes were calculated using the ellipsoid method for 2D ultrasound. For 3D, manual tracing was performed. Results: Sixty-two subjects were included, yielding 2,328 volume measurements. The mean age was 69 years (SD 6.6) and the median BMI was 24.3 kg/m2 (IQR 22.9–28.6). The mean difference between 2D measurements was significantly larger than the difference between 3D measurements (3.3 cm3 vs. 1.9 cm3, p <0.001). The intraclass correlation coefficient (ICC) between two sequential 2D measurements was 0.94 (p <0.001, 95% CI 0.94–0.95), and between two sequential 3D measurements 0.96 (p <0.001, 95% CI 0.96–0.97). The ICC between 2D and 3D measurements was 0.85 (95% CI 0.74–0.91, p <0.001). Conclusions: Our findings indicate that 3D ultrasound exhibits lower intra-observer variation when determining gallbladder volumes compared to 2D ultrasound. The discrepancy between the two methods increases with gallbladder volume.
- 5 August 2025
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 51 (11) , 1865-1877
Artificial Intelligence in Abdominal, Gynecological, Obstetric, Musculoskeletal, Vascular and Interventional Ultrasound
- 5 August 2025
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 51 (11) , 1865-1877
Artificial Intelligence in Abdominal, Gynecological, Obstetric, Musculoskeletal, Vascular and Interventional Ultrasound
- Open Access
- 21 June 2024
- Published by SRUMB - Romanian Society for Ultrasonography in Medicine and Biology in Medical Ultrasonography
- Vol. 26 (2) , 168-177
Comments and illustrations of the WFUMB CEUS liver guidelines: Rare benign focal liver lesion, part II
It is important to be familiar with the typical imaging features of the uncommon or even extremely rare focal liver lesions (FLL). Current guidelines of the World Federation for Ultrasound in Medicine and Biology (WFUMB) is aimed at assessing the usefulness of contrast enhanced ultrasound (CEUS) in the management of various FLL. In this review, we aim to summarize the ultrasound and CEUS characteristics with literature review of some extremely rare benign FLL, which might be helpful for improving diagnostic efficiency clinically
- 21 June 2024
- Published by SRUMB - Romanian Society for Ultrasonography in Medicine and Biology in Medical Ultrasonography
- Vol. 26 (2) , 168-177
Open AccessComments and illustrations of the WFUMB CEUS liver guidelines: Rare benign focal liver lesion, part II
It is important to be familiar with the typical imaging features of the uncommon or even extremely rare focal liver lesions (FLL). Current guidelines of the World Federation for Ultrasound in Medicine and Biology (WFUMB) is aimed at assessing the usefulness of contrast enhanced ultrasound (CEUS) in the management of various FLL. In this review, we aim to summarize the ultrasound and CEUS characteristics with literature review of some extremely rare benign FLL, which might be helpful for improving diagnostic efficiency clinically
- Open Access
- 5 June 2024
- Published by Elsevier in Microbes and Infection
- Vol. 26 (8) , 105372
Factors underlying the long-term efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome
- 5 June 2024
- Published by Elsevier in Microbes and Infection
- Vol. 26 (8) , 105372
Open AccessFactors underlying the long-term efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome
- Open Access
- 10 July 2023
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 36 (1) , e14641
Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome
Background: A previous study that introduced a Fecal microbiota transplantation (FMT) protocol with a high efficacy applied a combination of favorable factors.Aims: The present study aimed to evaluate some of these factors.Methods: This study included 186 patients with IBS randomized 1:1:1 into transplant administered to the colon (single LI), to the duodenum (single SI), or to the duodenum twice with a 1‐week interval (repeated SI). The patients provided a fecal sample and were asked to complete five questionnaires at baseline and at 3, 6, and 12 months after FMT. The fecal bacteria composition and dysbiosis index (DI) were analyzed using 16S rRNA gene PCR DNA amplification/probe hybridization covering regions V3–V9.Results: The response rate was significantly higher in single SI than in single LI at 12 months after FMT. Symptoms and quality of life improved in all the treated groups at all time intervals after FMT. The abdominal symptoms were significantly reduced and the quality of life improved for repeated SI compared with for single SI. DI significantly decreased in all the treated groups at all observation times after FMT. The bacterial profiles changed in all groups at all observation intervals. However, these changes differed between single LI and single SI/repeated SI.Conclusion: Administrating transplant to the small intestine had a long‐term higher response rate than that administrated to the large intestine, and led to long‐term colonization of beneficial bacteria. Repeating FMT had more effect on symptoms and quality of life than a single FMT. (www.clinicaltrials.gov: NCT04236843).
- 10 July 2023
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 36 (1) , e14641
Open AccessFactors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome
Background: A previous study that introduced a Fecal microbiota transplantation (FMT) protocol with a high efficacy applied a combination of favorable factors.Aims: The present study aimed to evaluate some of these factors.Methods: This study included 186 patients with IBS randomized 1:1:1 into transplant administered to the colon (single LI), to the duodenum (single SI), or to the duodenum twice with a 1‐week interval (repeated SI). The patients provided a fecal sample and were asked to complete five questionnaires at baseline and at 3, 6, and 12 months after FMT. The fecal bacteria composition and dysbiosis index (DI) were analyzed using 16S rRNA gene PCR DNA amplification/probe hybridization covering regions V3–V9.Results: The response rate was significantly higher in single SI than in single LI at 12 months after FMT. Symptoms and quality of life improved in all the treated groups at all time intervals after FMT. The abdominal symptoms were significantly reduced and the quality of life improved for repeated SI compared with for single SI. DI significantly decreased in all the treated groups at all observation times after FMT. The bacterial profiles changed in all groups at all observation intervals. However, these changes differed between single LI and single SI/repeated SI.Conclusion: Administrating transplant to the small intestine had a long‐term higher response rate than that administrated to the large intestine, and led to long‐term colonization of beneficial bacteria. Repeating FMT had more effect on symptoms and quality of life than a single FMT. (www.clinicaltrials.gov: NCT04236843).
- 2 February 2023
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (7) , 718-725
Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome
Gastrointestinal symptoms are common in ME/CFS, but there is a knowledge gap in the literature concerning gastrointestinal motility features and detailed symptom description.In this study, we aimed...
- 2 February 2023
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (7) , 718-725
Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome
Gastrointestinal symptoms are common in ME/CFS, but there is a knowledge gap in the literature concerning gastrointestinal motility features and detailed symptom description.In this study, we aimed...
- Open Access
- 29 November 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (12) , 2038
Ultrasound and Microbubbles Enhance Uptake of Doxorubicin in Murine Kidneys
The use of ultrasound and microbubble-enhanced drug delivery, commonly referred to as sonoporation, has reached numerous clinical trials and has shown favourable results. Nevertheless, the microbubbles and acoustic path also pass through healthy tissues. To date, the majority of studies have focused on the impact to diseased tissues and rarely evaluated the impact on healthy and collateral tissue. The aim of this study was to test the effect and feasibility of low-intensity sonoporation on healthy kidneys in a mouse model. In our work here, we used a clinical diagnostic ultrasound system (GE Vivid E9) with a C1-5 ultrasound transducer combined with a software modification for 20-µs-long pulses to induce the ultrasound-guided drug delivery of doxorubicin (DOX) in mice kidneys in combination with SonoVue® and Sonazoid™ microbubbles. The acoustic output settings were within the commonly used diagnostic ranges. Sonoporation with SonoVue® resulted in a significant decrease in weight vs. DOX alone (p = 0.0004) in the first nine days, whilst all other comparisons were not significant. Ultrasound alone resulted in a 381% increase in DOX uptake vs. DOX alone (p = 0.0004), whilst SonoVue® (p = 0.0001) and Sonazoid™ (p < 0.0001) further increased the uptake nine days after treatment (419% and 493%, respectively). No long-standing damage was observed in the kidneys via histology. In future sonoporation and drug uptake studies, we therefore suggest including an “ultrasound alone” group to verify the actual contribution of the individual components of the procedure on the drug uptake and to perform collateral damage studies to ensure there is no negative impact of low-intensity sonoporation on healthy tissues.
- 29 November 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (12) , 2038
Open AccessUltrasound and Microbubbles Enhance Uptake of Doxorubicin in Murine Kidneys
The use of ultrasound and microbubble-enhanced drug delivery, commonly referred to as sonoporation, has reached numerous clinical trials and has shown favourable results. Nevertheless, the microbubbles and acoustic path also pass through healthy tissues. To date, the majority of studies have focused on the impact to diseased tissues and rarely evaluated the impact on healthy and collateral tissue. The aim of this study was to test the effect and feasibility of low-intensity sonoporation on healthy kidneys in a mouse model. In our work here, we used a clinical diagnostic ultrasound system (GE Vivid E9) with a C1-5 ultrasound transducer combined with a software modification for 20-µs-long pulses to induce the ultrasound-guided drug delivery of doxorubicin (DOX) in mice kidneys in combination with SonoVue® and Sonazoid™ microbubbles. The acoustic output settings were within the commonly used diagnostic ranges. Sonoporation with SonoVue® resulted in a significant decrease in weight vs. DOX alone (p = 0.0004) in the first nine days, whilst all other comparisons were not significant. Ultrasound alone resulted in a 381% increase in DOX uptake vs. DOX alone (p = 0.0004), whilst SonoVue® (p = 0.0001) and Sonazoid™ (p < 0.0001) further increased the uptake nine days after treatment (419% and 493%, respectively). No long-standing damage was observed in the kidneys via histology. In future sonoporation and drug uptake studies, we therefore suggest including an “ultrasound alone” group to verify the actual contribution of the individual components of the procedure on the drug uptake and to perform collateral damage studies to ensure there is no negative impact of low-intensity sonoporation on healthy tissues.
- Open Access
- 23 October 2021
- Published by Wiley in United European Gastroenterology Journal
- Vol. 9 (10) , 1168-1177
Gastrointestinal transit and contractility in diabetic constipation: A wireless motility capsule study on diabetes patients and healthy controls
Background: Diabetic constipation is traditionally attributed to slow colonic transit, despite limited evidence. More than half of patients find treatment unsatisfactory. To improve treatment, there is a need for better diagnostic understanding of the condition.Objective: In this wireless motility capsule study, we aimed to investigate gastrointestinal transit and contractility in diabetes patients with and without constipation, and in healthy controls.Methods: We prospectively included type 1 or type 2 diabetes patients with gastrointestinal symptoms. Based on the Gastrointestinal Symptom Rating Scale we distinguished into two groups: with constipation and without constipation. Non‐diabetic controls were asymptomatic. All were examined with wireless motility capsule, determining transit times and contractility parameters.Results: 57 patients (42 women, 46 with type 1 diabetes) and 26 healthy controls (14 women) were included. We found no difference in transit times between diabetes patients with and without constipation. Compared to healthy controls (35:55, h:min), whole‐gut transit was slower in both diabetes patients with constipation (66:15, p = 0.03) and without constipation (71:16, p < 0.001). Small bowel motility index correlated rs = −0.32 (p = 0.01) with constipation symptoms.Conclusions: Diabetes patients with constipation had similar transit times as those without constipation. Both groups had slower whole‐gut transit than healthy controls. Constipation was associated with reduced small bowel, but not colonic contractility. Our results imply that other mechanisms than slow colonic transit may be more important in the pathogenesis of diabetic constipation.
- 23 October 2021
- Published by Wiley in United European Gastroenterology Journal
- Vol. 9 (10) , 1168-1177
Open AccessGastrointestinal transit and contractility in diabetic constipation: A wireless motility capsule study on diabetes patients and healthy controls
Background: Diabetic constipation is traditionally attributed to slow colonic transit, despite limited evidence. More than half of patients find treatment unsatisfactory. To improve treatment, there is a need for better diagnostic understanding of the condition.Objective: In this wireless motility capsule study, we aimed to investigate gastrointestinal transit and contractility in diabetes patients with and without constipation, and in healthy controls.Methods: We prospectively included type 1 or type 2 diabetes patients with gastrointestinal symptoms. Based on the Gastrointestinal Symptom Rating Scale we distinguished into two groups: with constipation and without constipation. Non‐diabetic controls were asymptomatic. All were examined with wireless motility capsule, determining transit times and contractility parameters.Results: 57 patients (42 women, 46 with type 1 diabetes) and 26 healthy controls (14 women) were included. We found no difference in transit times between diabetes patients with and without constipation. Compared to healthy controls (35:55, h:min), whole‐gut transit was slower in both diabetes patients with constipation (66:15, p = 0.03) and without constipation (71:16, p < 0.001). Small bowel motility index correlated rs = −0.32 (p = 0.01) with constipation symptoms.Conclusions: Diabetes patients with constipation had similar transit times as those without constipation. Both groups had slower whole‐gut transit than healthy controls. Constipation was associated with reduced small bowel, but not colonic contractility. Our results imply that other mechanisms than slow colonic transit may be more important in the pathogenesis of diabetic constipation.